Valeo Pharmainc (VPH.CN)
0.660 unch (unch) 03/29/22 [CNSX]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 10/31
(Values in thousands)
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,125 | 6,890 | 9,585 | 7,502 | 9,776 |
| Receivables | 4,775 | 5,611 | 5,135 | 6,565 | 5,360 |
| Inventories | 4,937 | 6,606 | 9,705 | 10,246 | 12,876 |
| TOTAL | $19,059 | $20,411 | $25,045 | $25,243 | $28,851 |
| Non-Current Assets | |||||
| PPE Net | 2,469 | 2,562 | 2,619 | 2,664 | 2,797 |
| Intangibles | 10,667 | 11,600 | 12,689 | 13,300 | 13,889 |
| TOTAL | $13,136 | $14,162 | $15,308 | $15,964 | $16,686 |
| Total Assets | $32,195 | $34,573 | $40,353 | $41,207 | $45,537 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 45,587 | 29,353 | 30,673 | 4,601 | N/A |
| Accounts payable and accrued liabilities | 10,088 | 8,537 | 9,584 | 3,992 | 10,247 |
| Accrued Expenses | 2,939 | 2,527 | 2,229 | 2,277 | 1,867 |
| TOTAL | $69,914 | $50,426 | $51,581 | $20,274 | $16,327 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,145 | 36,836 | 33,687 | 59,164 | 61,372 |
| aiOther Non-Current Liabilities | 880 | 874 | 777 | 771 | 1,533 |
| TOTAL | $25,315 | $39,016 | $35,785 | $61,270 | $64,256 |
| Total Liabilities | $95,229 | $89,442 | $87,366 | $81,544 | $80,583 |
| Shareholders' Equity | |||||
| Common Shares | 31,826 | 31,826 | 31,820 | 31,696 | 27,888 |
| Retained earnings | -105,139 | -96,947 | -89,136 | -82,264 | -73,019 |
| Other shareholders' equity | 5,562 | 5,563 | 5,654 | 5,649 | 5,612 |
| TOTAL | $-63,034 | $-54,869 | $-47,013 | $-40,337 | $-35,046 |
| Total Liabilities And Equity | $32,195 | $34,573 | $40,353 | $41,207 | $45,537 |